{"id":375800,"date":"2025-08-26T20:14:10","date_gmt":"2025-08-26T20:14:10","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/375800\/"},"modified":"2025-08-26T20:14:10","modified_gmt":"2025-08-26T20:14:10","slug":"dozens-of-drogheda-hospital-patients-had-pre-cancerous-cells-miscategorised-the-irish-times","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/375800\/","title":{"rendered":"Dozens of Drogheda hospital patients had pre-cancerous cells miscategorised \u2013 The Irish Times"},"content":{"rendered":"<p class=\"c-paragraph paywall \">A number of patients treated at <a href=\"https:\/\/www.irishtimes.com\/tags\/our-lady-of-lourdes-hospital\/\" target=\"_self\" rel=\"noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/our-lady-of-lourdes-hospital\/\">Our Lady of Lourdes Hospital<\/a> in <a href=\"https:\/\/www.irishtimes.com\/tags\/drogheda\/\" target=\"_self\" rel=\"noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/drogheda\/\">Drogheda<\/a> are being told this week of the miscategorisation of pre-cancerous cells as part of open disclosure procedures in the <a href=\"https:\/\/www.irishtimes.com\/tags\/health-service-executive-hse\/\" target=\"_self\" rel=\"noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/health-service-executive-hse\/\">HSE<\/a>. <\/p>\n<p class=\"c-paragraph paywall \">Three patients are being invited to what are known as \u201copen disclosure\u201d meetings at the hospital this week. <\/p>\n<p class=\"c-paragraph paywall \">Such meetings are organised between a healthcare provider and a patient, or their relevant person, following a patient safety incident.<\/p>\n<p class=\"c-paragraph paywall \">It is understood that in addition to these three patients, several dozen other patients will be sent letters advising them that the grading of their pre-cancerous cells has been altered following a review. <\/p>\n<p class=\"c-paragraph paywall \">In some instances, the severity of the grading of the pre-cancerous cells has been increased and in other cases decreased. <\/p>\n<p class=\"c-paragraph paywall \">It is understood in the case of one patient, a grading of mild, attributed initially to pre-cancerous cells, has been upgraded to high. <\/p>\n<p class=\"c-paragraph paywall \">In another case a mild grading has been found to be moderate. <\/p>\n<p class=\"c-paragraph paywall \">It is understood in another case, a patient underwent a second biopsy, which was found to be unnecessary. <\/p>\n<p class=\"c-paragraph paywall \">The moves follows a review of work carried out by one consultant at the hospital. <\/p>\n<p class=\"c-paragraph b-it-article-body__interstitial-link\">[\u00a0<a aria-label=\"Open related story\" class=\"c-link\" href=\"https:\/\/www.irishtimes.com\/world\/europe\/2025\/08\/22\/ai-just-as-accurate-as-radiologists-at-detecting-breast-cancer-study-finds\/\" rel=\"noreferrer noopener\" target=\"_blank\">AI just as accurate as radiologists at detecting breast cancer, study findsOpens in new window<\/a>\u00a0]<\/p>\n<p class=\"c-paragraph paywall \">In a statement on Tuesday, Our Lady of Lourdes Hospital said: \u201cIn the course of our quality assurance process in the hospital, we commissioned an independent lookback of all histopathology slides across various specialities in relation to one consultant, focusing on a period from February to November 2024\u201d.<\/p>\n<p class=\"c-paragraph paywall \">\u201cThis review is under way and any patients in relation to whom any findings are relevant will be contacted directly by the hospital. HSE Dublin and North East has provided necessary information to the HSE in line with the National Patient Safety Briefing Protocol.\u201d<\/p>\n<p class=\"c-paragraph paywall \">The hospital review is continuing and<b> <\/b>it is possible<b> <\/b>other patients may be invited to similar open disclosure meetings in the future. <\/p>\n<p class=\"c-paragraph paywall \">Stephen McMahon, co-founder and director of the Irish Patients\u2019 Association (IPA), said full transparency was important.  He called on senior management to answer questions about when exactly it became aware of this issue and how many patients in total are affected. <\/p>\n<p class=\"c-paragraph paywall \">\u201cPatients should not be left waiting in fear for a dreaded letter, every affected person must be written to immediately,\u201d he said.<\/p>\n<p class=\"c-paragraph paywall \">Though acknowledging this issue is separate to previous controversies in <a href=\"https:\/\/www.irishtimes.com\/tags\/cervical-check-scandal\/\" target=\"_self\" rel=\"noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/cervical-check-scandal\/\">CervicalCheck<\/a> as it does not relate to a screening programme, Mr McMahon said it \u201ccarries awful shadows of previous debacles\u201d.<\/p>\n<p class=\"c-paragraph paywall \">\u201cOnly urgent transparency and accountability will fully inform those affected, ensure they and their families receive the supports they need, and protect future patients.\u201d<\/p>\n<p class=\"c-paragraph paywall \">He outlined a number of \u201ckey questions\u201d following the news, including whether this miscategorisation of pre-cancerous cells will affect the prognosis of any patients and what systems are in place now to prevent this from happening again. <\/p>\n<p class=\"c-paragraph paywall \">Sinn Fein\u2019s health spokesman David Cullinane said the open disclosure meetings must \u201ctake place urgently\u201d.<\/p>\n<p class=\"c-paragraph paywall \">\u201cThis will be a worrying time for any patient who receives a letter to say their histopathology slides are under review. Face to face meetings and every support must be given to these patients,\u201d he said.<\/p>\n<p class=\"c-paragraph paywall \">\u201cObviously a full investigation will be needed to establish how and why there was so many slides miscategorised and measures put in place to ensure this does not happen again.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"A number of patients treated at Our Lady of Lourdes Hospital in Drogheda are being told this week&hellip;\n","protected":false},"author":2,"featured_media":375801,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[1204,131277,105,4348,21110,16,15],"class_list":{"0":"post-375800","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-cancer","9":"tag-drogheda","10":"tag-health","11":"tag-healthcare","12":"tag-hse","13":"tag-uk","14":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115096903280213519","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/375800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=375800"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/375800\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/375801"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=375800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=375800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=375800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}